Horizon Kinetics Medical ETF Rating $35.35 -0.49 (-1.37%) Closing price 09/23/2026 02:55 PM EasternExtended Trading$35.39 +0.04 (+0.12%) As of 04:01 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsRatings Horizon Kinetics Medical ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.MEDX Aggregate RatingModerate Buy 2.69Holdings in MEDX have an aggregate rating of Moderate Buy based on 405 analyst ratings issued in the past year covering 22 companies (79.5% of the portfolio).MEDX Aggregate Price Target$35.35High Prediction$35.35Average Prediction$35.35Low Prediction$35.35Holdings in MEDX have an aggregate price target of $35.35 and a range of $35.35 to $35.35 covering 22 companies (79.5% of the portfolio).MEDX Consensus Ratings of HoldingsStrong Buy1 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Horizon Kinetics Medical ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 22 MEDX Holdings ExportWeight In ETFCompanyShare PriceConsensus RatingConsensus Price TargetPossible UpsideNumber of RatingsMarketRank™Indicator(s)ViewRatings18.35%LLYEli Lilly and Company$1,153.69-1.4%Moderate Buy$1,305.25 13.1%304.7503 of 5 starsTrending NewsAnalyst ForecastAnalyst Revision9.61%ABBVAbbVie$265.43+0.1%Moderate Buy$276.64 4.2%253.8324 of 5 starsTrending News6.16%JNJJohnson & Johnson$269.01-0.1%Moderate Buy$274.13 1.9%254.4069 of 5 starsTrending NewsAnalyst ForecastAnalyst Revision5.10%ALKSAlkermes$42.13-2.7%Moderate Buy$54.75 30.0%183.509 of 5 starsTrending NewsAnalyst Forecast4.69%MRKMerck & Co., Inc.$148.07-1.9%Moderate Buy$154.24 4.2%244.1562 of 5 starsTrending News4.50%BMYBristol Myers Squibb$61.14-1.8%Moderate Buy$67.06 9.7%254.7421 of 5 starsAnalyst Forecast4.25%AMGNAmgen$406.09-1.0%Hold$383.46 -5.6%303.586 of 5 starsTrending NewsAnalyst ForecastAnalyst Revision3.40%PFEPfizer$28.16+0.8%Hold$28.39 0.8%212.7791 of 5 starsTrending News3.24%BIIBBiogen$227.53+1.0%Moderate Buy$230.14 1.1%322.5385 of 5 stars2.89%ALNYAlnylam Pharmaceuticals$246.51-2.0%Moderate Buy$367.20 49.0%234.2224 of 5 starsAnalyst Forecast2.87%CRSPCRISPR Therapeutics$55.76-5.5%Moderate Buy$67.94 21.8%172.5422 of 5 starsInsider Trade2.76%IONSIonis Pharmaceuticals$43.93-4.0%Moderate Buy$90.50 106.0%223.1177 of 5 starsTrending NewsAnalyst Forecast2.73%GSKGSK$49.75-1.9%Hold$56.50 13.6%113.7861 of 5 starsDividend Cut2.70%REGNRegeneron Pharmaceuticals$801.82-0.3%Moderate Buy$802.18 0.0%243.7127 of 5 starsAnalyst Forecast1.12%BEAMBeam Therapeutics$24.37-6.0%Moderate Buy$49.00 101.1%131.9988 of 5 stars0.95%GALTGalectin Therapeutics$4.05-2.2%Hold$11.00 171.6%31.6444 of 5 stars0.88%REPLReplimune Group$12.96-3.8%Moderate Buy$12.00 -7.4%101.7056 of 5 stars0.84%NTLAIntellia Therapeutics$12.33-2.8%Hold$20.98 70.1%232.8933 of 5 stars0.75%SDZNYSandoz Group$86.43-0.1%Strong Buy51.5483 of 5 starsAnalyst Revision0.63%VNDAVanda Pharmaceuticals$5.04-3.3%Moderate Buy$13.08 159.6%92.4386 of 5 starsNews CoveragePositive NewsAnalyst Forecast0.62%HLNHaleon$9.12-1.4%Moderate Buy92.9919 of 5 starsAnalyst Forecast0.41%EDITEditas Medicine$2.69-7.9%Moderate Buy$5.80 115.6%62.5051 of 5 starsNews CoverageAnalyst UpgradeGap Up This page (NASDAQ:MEDX) was last updated on 9/24/2026 by MarketBeat.com Staff. From Our PartnersHow to get a stake in Anthropic — before the IPOAnthropic, the maker of Claude AI, has reportedly filed for an IPO that could arrive as early as October. Its ...Weiss Ratings | SponsoredWhy I believe the AI market will split in Q4Matt McCall, who recommended Nvidia near $6 a share, says the AI market is splitting in two - just like the do...The Oxford Club | SponsoredShocking new footage just releasedGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...Digest Publishing | SponsoredIf you keep cash in a U.S. bank account… read this NOWSince 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every d...Banyan Hill Publishing | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredOn October 7th, your “safest” assets are at riskJeff Brown called Nvidia's rise of over 27,000 percent and warned in early 2024 that inflation would outlast W...Brownstone Research | SponsoredWhile SpaceX Gets the Spotlight, FJET Is Building What Comes Next!Starfighters Space (NYSE: FJET) operates the world's only commercial fleet of flight-ready Mach 2+ F-104 Starf...Trading Wire | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Horizon Kinetics Medical ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Horizon Kinetics Medical ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
